NICE management of acne guideline
This Guidelines summary covers the management of acne in primary care, including advice on treatments and the impact on mental health and wellbeing
NICE secondary bacterial infection of common skin conditions
This Guidelines summary covers an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions
COVID-19 rapid guideline on dermatological conditions
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
NICE eczema in under 12s guideline
An easy-to-follow NICE guideline summary on the management of atopic eczema in children under 12
NICE CKS on rosacea
A summary of guidance to assist healthcare professionals on the diagnosis and management of rosacea
Educational resources
Managing acne well—a summary of the 2021 NICE guideline
Information intended for UK healthcare professionals only. This promotional supplement has been commissioned and funded by Galderma and developed in partnership with Guidelines.
View Epiduo Gel 0.1% (0.1% adapalene & 2.5% benzoyl peroxide) prescribing information and adverse event reporting information.
View Epiduo Gel 0.3%/2.5 % (0.3% adapalene & 2.5% benzoyl peroxide) prescribing information and adverse event reporting information.
UKI-EDG-2100027
Date of preparation: October 2021
Soolantra® (ivermectin) 10 mg/g cream
This prescribing summary card was developed from content provided by Galderma UK Ltd. Information intended for UK healthcare professionals only.
View Soolantra® (ivermectin) 10 mg/g cream prescribing and adverse event reporting information.
UKI-SOC-2100031 September 2021
Recommending emollients for patients with atopic dermatitis or dry skin conditions
This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines.
Date of preparation: January 2021